The Princess Margaret (PM) Cancer Centre is the largest integrated cancer research, teaching and treatment centre in Canada. Its research institute, formerly known as the Ontario Cancer Institute (OCI), includes internationally recognized researchers and cutting-edge research infrastructure. The Centre focuses on cancer research across various fields including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics. PM’s laboratories and facilities are primarily located at the Centre itself (610 University Avenue) and at the Princess Margaret Cancer Research Tower (in the MaRS Centre).
PM Cancer Centre’s researchers are grouped into the following programs based on their research:
| PROGRAMS | CHAIRS |
| Cancer Biology and Imaging | Razq Hakem |
| Computational Biology and Medicine | Michael Hoffman |
| Genetics and Epigenetics | Mathieu Lupien |
| Immuno-Oncology | Naoto Hirano |
| Protein Structure and Function | Cheryl Arrowsmith |
| Stem Cells | Catherine O'Brien |
| Supportive Care | Camilla Zimmermann |
The Princess Margaret (PM) Cancer Centre is the largest integrated cancer research, teaching and treatment centre in Canada. Its research institute, formerly known as the Ontario Cancer Institute (OCI), includes internationally recognized researchers and cutting-edge research infrastructure. The Centre focuses on cancer research across various fields including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics. PM’s laboratories and facilities are primarily located at the Centre itself (610 University Avenue) and at the Princess Margaret Cancer Research Tower (in the MaRS Centre).
PM Cancer Centre’s researchers are grouped into the following categories based on their research program:
Research Directorate, Princess Margaret Cancer Centre
610 University Avenue
Toronto, ON
M5G 2M9
CANADA
- Cancer Biology and Imaging
Built on the long tradition of exemplary research expertise, PM Cancer Centre's Cancer Biology and Imaging multidisciplinary program is committed to themes in cell, molecular and mechanistic biology of cancer, molecular pathology, personalized molecular cancer imaging and cancer models. The collaborative nature of the program aims for transforming discoveries and rapid translation through scientific innovation, research integration and clinical implementation.
Scientist, Senior Scientist, Clincian Scientist
Hakem, Razq (Chair)
Affliate Scientist
Nixon, Kevin
Emeritus Scientist
Boyd, Norman
Rauth, Mike
Staff Scientist
Adjunt Scientist
- Computational Biology and Medicine
The Computional Biology and Medicine Program (CBMP) is home to Scientists and Clinicians interested in computational methods used to aggregate, analyze and share biomedical data for basic, translational and clinical research. By assessing how emerging computational technologies can be leveraged to address scientific and clinical gaps, CMBP will work toward the dissemination of multimodal data and software tools, education regarding their use, alignment with internal and external initiatives, and foster synergies within and across programs
.
For more information, visit https://cbmp.ca/ or contact Paul Brogee (Program Manager; Paul.Brogee@uhnresearch.ca).
Scientist, Senior Scientist, Clinician Scientist
Hoffman, Michael (Chair)
Seuntjens, Jan
Affiliate Scientist
Emeritus Scientist
Adjunct Scientist
Clinical Champion
Grant, Robert
Haider, Masoom
- Genetics and Epigenetics
The Genetics and Epigenetics Program focuses on the fundamental genetic, epigenetic, and genomic mechanisms underlying cancer development, progression, and treatment, with the aim of translating basic research discoveries and new technologies into clinical application. The goals of this program are to align and synergize research within the team, facilitate collaborations between basic research and clinical groups, build genetic and epigenetic platforms and resources, and prepare the team for internal and external grant applications.
Scientist, Senior Scientist, Clinician Scientist
Lupien, Mathieu (chair)
Affiliate Scientist
Bunda, Severa
Zeng, Yong
Staff Scientist
Orouji, Elias
Clinical Champion
Berman, Hal
- Immuno-Oncology
The immune therapy program will make cutting edge contributions to the field of immune-oncology by uncovering novel findings in basic and translational research, as well as learning from patient responses in clinical trials to improve response rates and quality of life. Our goal is also to develop novel technologies and reagents to remain at the forefront of this field.
Scientist, Senior Scientist, Clinician Scientist
Hirano, Naoto (Chair)
Affiliate Scientist
Emeritus Scientist
Staff Scientist
Nguyen, Linh
Clinical Champion
Gerbitz, Armin
Saibil, Sam
- Protein Structure and Function
We aim to understand the molecular "machines" that perform the critical cellular processes impacted in cancer related diseases. Using a variety of cutting-edge technologies to characterize the regulation, structure and function of proteins that drive, or are affected by, cancer, we aim to identify new therapeutic targets and biomarkers, and to develop new tools to target protein functions linked to disease.
Scientist, Senior Scientist, Clinician Scientist
Arrowsmith, Cheryl H (Chair)
Emeritus Scientist
Pai, Emil
Rose, David
Staff Scientist
Marshall, Chris
Seabrook, Genevieve
- Stem Cells
The focus of the Stem Cell Program is the functional interrogation of normal and malignant stem cells at both the clonal and molecular level. Our strategy being to identify genetic and non-genetic drivers that maintain cancer cells in a stem-cell state and thereby sustain tumour growth. The overarching goal of the stem cell program is to translate our discoveries into novel therapeutic strategies designed to target cancer stem cells and as a result improve outcomes for cancer patients.
Scientist, Senior Scientist, Clinician Scientist
O'Brien, Catherine Adell (Chair)
Affiliate Scientist
Ghadie, Mohamed
Jahangiri Tazehkand Soheil
Sarathy, Chaitra
Emeritus Scientist
- Supportive Care
The main areas of research for the Supportive Care Program are Psychosocial Oncology, Palliative Care, and Cancer Survivorship and Rehabilitation. These areas overlap and include biopsychosocial, as well as neurocognitive effects of cancer and its treatment on patients and their families across the disease trajectory. These areas are investigated through longitudinal, intervention and implementation research to reduce suffering, optimize functioning and health, and improve quality of life throughout the course of illness.
Scientist, Senior Scientist, Clinician Scientist
Zimmermann, Camilla (Chair)
Affiliate Scientist
Emeritus Scientist
